U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
123421123421Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: TAK-875https://ClinicalTrials.gov/show/NCT00949091
123422123422Omalizumab in the Treatment of Peanut AllergyActive, not recruitingNo Results AvailableFood Allergy|Peanut AllergyDrug: omalizumabhttps://ClinicalTrials.gov/show/NCT00949078
123423123423Intravenous Immunoglobulins in Complex-regional Pain SyndromeNot yet recruitingNo Results AvailableComplex Regional Pain Syndrome Type 1Biological: intravenous immunoglobulinshttps://ClinicalTrials.gov/show/NCT00949065
123424123424Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for CancerRecruitingNo Results AvailableCancerGenetic: DNA analysis|Genetic: polymorphism analysis|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration|Procedure: assessment of therapy complications|Procedure: evaluation of cancer risk factorshttps://ClinicalTrials.gov/show/NCT00949052
123425123425Study Comparing Isolated Pelvic Perfusion With TNF-α 0.3 mg and Melphalan 1.5 mg/kg Versus Standard Treatment in Patients With Non Resectable, Recurrent Gynaecologic or Digestive Pelvic CancerCompletedNo Results AvailableGynaecologic or Digestive Pelvic CancerDrug: Isolated pelvis perfusion|Radiation: radiotherapy|Procedure: Surgeryhttps://ClinicalTrials.gov/show/NCT00949039
123426123426Assessment of Systemically Administered Torisel Delivery to Brain Tumors by Intratumoral MicrodialysisWithdrawnNo Results AvailableBrain NeoplasmsDrug: Temsirolimus (Torisel)https://ClinicalTrials.gov/show/NCT00949026
123427123427S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313CompletedNo Results AvailableBreast CancerOther: immunohistochemistry staining method|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00949013
123428123428AnalyST Treadmill StudyCompletedNo Results AvailableIschemic Heart DiseaseDevice: ICD Implantationhttps://ClinicalTrials.gov/show/NCT00949000
123429123429Mechanism Based Resistance to AspirinCompletedNo Results AvailableAspirin Resistance|Pharmacological Aspirin Non-responsivenessDrug: Aspirinhttps://ClinicalTrials.gov/show/NCT00948987
123430123430Variations of Cognitive Behavior Therapy for Social Anxiety DisorderRecruitingNo Results AvailableSocial Anxiety DisorderBehavioral: Cognitive Therapy|Behavioral: Acceptance and Commitment Therapyhttps://ClinicalTrials.gov/show/NCT00948974
123431123431A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1CompletedNo Results AvailableAdvanced MalignanciesBiological: CDX-1401 in combination with Resiquimod and/or Poly-ICLChttps://ClinicalTrials.gov/show/NCT00948961
123432123432Mentor Adjunct Study for Silicone Gel-Filled Mammary ProsthesisApproved for marketingNo Results AvailableBreast ReconstructionDevice: Silicone Gel-Filled Mammary Prostheseshttps://ClinicalTrials.gov/show/NCT00948948
123433123433Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract AdenocarcinomaActive, not recruitingNo Results AvailableBiliary Cancer|CholangiocarcinomaDrug: Gemcitabine, Irinotecan, Panitumumabhttps://ClinicalTrials.gov/show/NCT00948935
123434123434Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple MyelomaActive, not recruitingNo Results AvailableMultiple MyelomaDrug: Bortezomib|Drug: Melphalan|Procedure: Autologous Stem Cell Transplant|Drug: Bortezomib|Drug: Fludarabine|Drug: Melphalanhttps://ClinicalTrials.gov/show/NCT00948922
123435123435Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer's DiseaseDrug: Placebo|Drug: ABT-126|Drug: donepezilhttps://ClinicalTrials.gov/show/NCT00948909
123436123436Chemopreventive Therapy for Malaria in Ugandan ChildrenCompletedHas ResultsMalariaDrug: trimethoprim-sulfamethoxazole (TS; TMP/SMX)|Drug: sulfadoxine-pyrimethamine (SP)|Drug: dihydroartemisinin-piperaquine (DP)https://ClinicalTrials.gov/show/NCT00948896
123437123437Study of Cancers After Solid Organs TransplantsCompletedNo Results AvailableCancer|Organ Transplantationhttps://ClinicalTrials.gov/show/NCT00948883
123438123438Trial of Chinese Prescription Shugan Decoction on Irritable Bowel Syndrome(Diarrhea Type)CompletedNo Results AvailableIrritable Bowel Syndrome|Traditional Chinese MedicineDrug: Shugan decoctionhttps://ClinicalTrials.gov/show/NCT00948870
123439123439Dehydroepiandrosterone (DHEA) Treatment and Premature Ovarian Failure (POF)TerminatedHas ResultsPremature Ovarian FailureDietary Supplement: Dehydroepiandrosterone|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT00948857
123440123440Automatic Detection of Falls and Near FallsNot yet recruitingNo Results AvailableFalls|MisstepsDevice: Hybrid (3-d accelerometers, and gyroscopes)https://ClinicalTrials.gov/show/NCT00948844
123441123441Osteocel® Plus in Anterior Lumbar Interbody Fusion (ALIF)CompletedNo Results AvailableDegenerative Disc Disease, LumbarBiological: Osteocel Plushttps://ClinicalTrials.gov/show/NCT00948831
123442123442Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With ConstipationCompletedHas ResultsIrritable Bowel Syndrome Characterized by ConstipationDrug: Linaclotide 290 micrograms|Drug: Matching placebohttps://ClinicalTrials.gov/show/NCT00948818
123443123443Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization TreatmentRecruitingNo Results AvailableInfertilityDrug: GnRH agonist|Drug: Controlhttps://ClinicalTrials.gov/show/NCT00948805
123444123444Study of the Effect of Differing Platelet Transfusion Times in NeonatesCompletedHas ResultsThrombocytopeniaProcedure: Short platelet transfusion|Procedure: Long platelet transfusionhttps://ClinicalTrials.gov/show/NCT00948792
123445123445Antibiotic Education for Children in an Emergency Care UnitCompletedNo Results AvailableOtorhinolaryngologic Diseases|Respiratory Tract Infections|Pyelonephritis|Urinary Tract InfectionsOther: antibiotic education for children in an emergency care unit|Other: antibiotic education for children in an emergency care unithttps://ClinicalTrials.gov/show/NCT00948779
123446123446Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44CompletedHas ResultsAlzheimer's DiseaseDrug: Rivastigmine 4.6 mg/24 h (5 cm^2)|Drug: Rivastigmine 9.5 mg/24 h (10 cm^2)|Drug: Rivastigmine 13.3 mg/24 h (15 cm^2)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00948766
123447123447Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell TransplantationCompletedNo Results AvailableGraft-versus-host Disease|Hematopoietic Stem Cell TransplantationDrug: Maravirochttps://ClinicalTrials.gov/show/NCT00948753
123448123448The Effect of Vitamin D on Urinary Calcium Excretion in Kidney Stone Formers With High Urinary CalciumActive, not recruitingNo Results AvailableVitamin D Deficiency|NephrolithiasisDrug: vitamin D (ergocalciferol)https://ClinicalTrials.gov/show/NCT00948740
123449123449Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell TransplantationCompletedNo Results AvailableHematopoietic Stem Cell Transplantation|Graft Versus Host DiseaseBehavioral: Dose adaptation according to CN activity monitoring|Drug: Cyclosporine (CsA)https://ClinicalTrials.gov/show/NCT00948727
123450123450Support for Cardiovascular Health in African American Primary Care PatientsCompletedNo Results AvailableCardiovascular Diseases|Blood PressureBehavioral: Peer Coach Phone Calls|Behavioral: Health Educator Visits|Other: written materialshttps://ClinicalTrials.gov/show/NCT00948714

* Görseller ve İçerik tekif hakkına sahip olabilir